Myocarditis, Pericarditis and Cardiomyopathy After COVID-19 Vaccination

Heart Lung Circ. 2021 Oct;30(10):1425-1429. doi: 10.1016/j.hlc.2021.07.011. Epub 2021 Jul 31.
No abstract available

Keywords: ANZSCTS; Australia; COVID-19; CSANZ; Cardiomyopathy; Cardiovascular disease; Myocarditis; Pericarditis; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); mRNA vaccine.

Publication types

  • Editorial